Sociodemographic and metabolic risk characteristics associated with metabolic weight categories in the Women's Health Initiative

Cardiovascular Endocrinology & Metabolism
Amber R Cordola HsuHoda Anton-Culver

Abstract

To identify sociodemographic and metabolic correlates of weight categories in postmenopausal women. The Women's Health Initiative enrolled 161 808 postmenopausal women ages 50-79. We included those free of cardiovascular disease (CVD) and with CVD risk factors and biomarkers (n = 19 412). Normal weight was defined as a BMI ≥18.5 and <25 kg/m2 and waist circumference <88 cm and overweight/obesity as a BMI ≥25 kg/m2 or waist circumference ≥88 cm. Metabolically healthy was based on <2 and metabolically unhealthy ≥2 traits: triglycerides ≥150 mg/dl, systolic blood pressure (BP) ≥130 mmHg or diastolic BP ≥85 mmHg or antihypertensives or diuretics, fasting glucose ≥100 mg/dl or diabetes medication, and high-density lipoprotein cholesterol <50 mg/dl. Polytomous multinomial logistic regression with generalized link logit function provided the odds of metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUHNW), metabolically healthy overweight/obese (MHO), and metabolically unhealthy overweight/obese (MUHO) according to demographic and risk factor measures. Among the 19 412 postmenopausal women, 2369 (12.2%) participants had prevalent diabetes. Advanced age was associated with an increased odds of MUHNW as ...Continue Reading

References

Aug 1, 1981·The American Journal of Clinical Nutrition·N B RudermanP Berchtold
May 20, 1998·Diabetes·N RudermanS Schneider
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Dec 6, 2001·Metabolism: Clinical and Experimental·E A Sims
Nov 28, 2002·Journal of Gastroenterology and Hepatology·Brian P MulhallZobair M Younossi
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·Molly C Carr
Oct 4, 2005·Lancet·David W Haslam, W Philip T James
Apr 11, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·David C W LauUNKNOWN Obesity Canada Clinical Practice Guidelines Expert Panel
Dec 14, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Y ChangS I Cho
Mar 16, 2013·Diabetes Care·Sarah L AppletonUNKNOWN North West Adelaide Health Study Team
Apr 6, 2013·The Journal of Clinical Endocrinology and Metabolism·Federico SoriguerGemma Rojo-Martínez
Mar 4, 2014·Journal of Diabetes and Its Complications·Nathaniel J ColemanLeon Fogelfeld
Jul 12, 2014·European Journal of Endocrinology·Matthias Blüher
Dec 20, 2015·Metabolism: Clinical and Experimental·Hannah MathewChristos S Mantzoros

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.